CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Non-hospitalization proceduresWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug1268 Hospital admission Wiki 1.00
drug3281 home care monitoring Wiki 1.00

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Brazilian COVID-19 Registry for Clinical Presentation of Individuals With COVID-19: a National, Multicentre, Prospective Observational Study (SARS-Brazil)

This is a registry-based cohort study of all adult patients (≥18 years) with confirmed or suspected SARS-CoV-2 infection. The main goal is to describe mortality incidence, demographic characteristics, coexisting conditions, treatments, outcomes among SARS-CoV2 infected patients. A secondary goal is to identify biological factors (OMICS - genomic, proteomic and metabolomics characterization) associated with severity conditions for these patients.

NCT04479488 Covid19 SARS-CoV Infection Other: Hospital admission Other: Non-hospitalization procedures
MeSH:Coronavirus Infections Severe Acute Respiratory Syndrome

Primary Outcomes

Description: All-cause mortality rates at 60 days

Measure: All-cause mortality

Time: 60 Days

Secondary Outcomes

Description: To assess the prevalence and course of symptoms of COVID-19 infection of patients followed during a period of 60 days

Measure: Incidence and course of symptoms of COVID-19 infection

Time: 60 Days

Description: Rate of patients requiring hospitalization and re-hospitalization (readmission to the hospital occurring within 60 days after admission)

Measure: Hospitalizations

Time: 60 Days

Description: Rate of patients requiring oxygen therapy

Measure: Oxygen supplementation

Time: 60 Days

Description: Rate of patients requiring invasive mechanical ventilation

Measure: Use of invasive mechanical ventilation

Time: 60 Days

Description: ICU length of stay

Measure: Intensive care unit length of stay

Time: 60 Days

Other Outcomes

Description: Percentual changes in serum proteome of patients with mild or moderate to severe disease

Measure: Serum proteomic

Time: 60 Days

Description: Percentual changes in serum metabolome of patients with mild or moderate to severe disease

Measure: Serum metabolomic

Time: 60 Days

Description: Determination of whole genome sequence and transcriptomic of mild or moderate to severe disease

Measure: Genomic description

Time: 60 Days

No related HPO nodes (Using clinical trials)